Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Kindstar Diagnostics to Offer BG Medicine’s Cardiac Test

publication date: Oct 25, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
BG Medicine, a US maker of cardiac diagnostic tests, has entered into an agreement with Kindstar Diagnostics Co., the largest diagnostic testing lab in China. Under the terms of the pact, Kindstar will be able to offer BGM’s galectin-3 testing services in China. In the US, the BGM Galectin-3® test has been approved in the US to help assess the prognosis of patients with chronic heart failure. More details....

Stock Symbol: (NSDQ: BGMD)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors